SUNNIFORECAST - A phase II study of Nivolumab in combination with
   Ipilimumab versus Standard of care in advanced or metastatic non-clear
   cell renal cell carcinoma

Title:: SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma
Document type:: Meeting Abstract
Author(s):: Scheich, S.; Ahrens, M.; Goekbuget, N.; Boleti, E.; Burkholder, I; Escudier, B. J.; Goebell, P. J.; Gruenwald, V; Gschwend, J.; Retz, M.; Hartmann, A.; Maroto Rey, J. P.; Miller, K.; Grimm, M. -O; Siemer, S.; Panic, A.; Bergmann, L.
Journal title abbreviation:: Oncology Research and Treatment
Year:: 2018
Journal volume:: 41
Pages contribution:: 205-205
Print-ISSN:: 2296-5270
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: